Midlife Pep Does Not Curtail Alzheimer’s Biomarkers
Exercising the brain and body in middle age may not limit progression of Alzheimer’s pathology.
6552 RESULTS
Sort By:
Exercising the brain and body in middle age may not limit progression of Alzheimer’s pathology.
Researchers confirm that new cases of dementia are on the wane in the United Kingdom, with the greatest benefits among older men.
It was not easy, but it got done—and the catch looks nothing like prior synthetic or mouse versions of these species.
Scientists match up PET scans of neurofibrillary tangles against Aβ imaging, CSF measures, and cognitive tests to see how biomarkers change relative to function.
Anti-platelet therapy might treat vascular dementia, researchers suggest.
Levels of neurofilament light in blood and spinal fluid of mice reflected brain pathology and changed with treatment.
Take a three-dimensional tour of the plaques and tangles of mouse and human brains as they develop Alzheimer’s disease-related pathology.
Researchers report that tau accumulation in the cortex associates with cognitive impairment in people with ongoing synucleinopathy. Aβ is not necessary for this type of tauopathy.
A mouse that expresses ApoE only in the blood loses synapses in the brain, but appears to learn and remember normally.
When mixed with arachidonic acid, α-synuclein formed soluble multimers rather than toxic fibrils. Researchers speculate that these multimers represent the physiological norm in synaptic compartments.
Two labs report that dipeptide repeats derived from C9ORF72 latch onto TDP43, FUS, and other proteins that form liquid organelles. The liquid then gels, retarding cellular functions.
As reported at meetings, Merck’s BACE inhibitor reduced CSF Aβ in animals and people with apparently few side effects. Researchers express optimism for the drug and others in its class.
Mice expressing a mutant version of human UBQLN2 develop TDP-43 pathology in their spinal cords, while losing motor neurons, muscle mass, and muscle innervation of with age.
Evidence from a nationally representative sample suggests a 12-year drop in age-specific risk of dementia.
The vascular cells, which die off in Alzheimer’s disease, may be crucial for regulating blood supply to the brain.
No filters selected